Skip to main content
Log in

Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor

  • Original Paper
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

Insulinoma-associated protein 1 (INSM1) is an important biomarker of Achaete-scute homolog-like 1-driven pathways. For diagnosis of pancreatic neuroendocrine tumors (PanNET), chromogranin A (CGA), synaptophysin (SYP), and neural cell adhesion molecule (NCAM) were also considered as potential biomarkers. However, it is often difficult to diagnose it immunohistochemically. Hence, we examined the expression pattern of INSM1 in pancreatic solid tumors. We detected INSM1, CGA, SYP, and NCAM immunohistochemically, in 27 cases of NET [pure type: 25 cases, mixed adenoneuroendocrine carcinoma (MANEC): 2 cases]. We included 5 cases of solid-pseudopapillary neoplasm (SPN), 7 cases of acinar cell carcinoma (ACC), and 15 cases of pancreatic ductal adenocarcinoma (PDAC) as the control group. Nuclear expression of INSM1 was found in all PanNET pure type cases. However, expression of INSM1 was negative in PDAC, ACC, and SPN in all cases, whereas faint expression was seen in the cytoplasm from SPN. MANEC comprises of two components: neuroendocrine carcinoma and adenocarcinoma components. The NET component was positive for INSM1 expression, whereas the PDAC component does not express INSM1, which aids in distinguishing these components. Our results suggest that INSM1 is a useful immunohistochemical marker for diagnosing pancreatic neuroendocrine tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yang M, Zeng L, Zhang Y, Wang WG, Wang L, Ke NW, Liu XB, Tian BL (2015) TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution. Medicine (Baltimore) 94:e660

    Article  Google Scholar 

  2. Klimstra DS, Arnold R, Capella C, Hruban RH, Kloppel G, Komminoth P, Solcia E, Rindi G (2010) Neuroendocrine neoplasm of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Thise ND (eds) WHO classification of tumors of the digestive system. IARC Press, Lyon, pp 322–326

    Google Scholar 

  3. Kasajima A, Yazdani S, Sasano H (2015) Pathology diagnosis of pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci 22:586–593

    Article  PubMed  Google Scholar 

  4. Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, Krasinskas AM, Jang KT, Frankel WL, Balci S, Sigel C, Klimstra DS (2015) The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 39:683–690

    Article  PubMed  PubMed Central  Google Scholar 

  5. Meriden Z, Shi C, Edil BH, Ellison T, Wolfgang CL, Cornish TC, Schulick RD, Hruban RH (2011) Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis. Am J Surg Pathol 35:981–988

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ohike N, Kosmahl M, Kloppel G (2004) Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 445:231–235

    Article  PubMed  Google Scholar 

  7. Notohara K, Hamazaki S, Tsukayama C, Nakamoto S, Kawabata K, Mizobuchi K, Sakamoto K, Okada S (2000) Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol 24:1361–1371

    Article  CAS  PubMed  Google Scholar 

  8. Fujino K, Motooka Y, Hassan WA, Ali Abdalla MO, Sato Y, Kudoh S, Hasegawa K, Niimori-Kita K, Kobayashi H, Kubota I, Wakimoto J, Suzuki M, Ito T (2015) Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung cancer. Am J Pathol 185:3164–3177

    Article  CAS  PubMed  Google Scholar 

  9. Wang H, Chen Y, Fernandez-Del Castillo C, Yilmaz O, Deshpande V (2013) Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway. Mod Pathol 26:139–147

    Article  CAS  PubMed  Google Scholar 

  10. Fujino K, Yasufuku K, Kudoh S, Motooka Y, Sato Y, Wakimoto J, Kubota I, Suzuki M, Ito T (2017) INSM1 is the best marker for the diagnosis of neuroendocrine tumors: comparison with CGA, SYP and CD56. Int J Clin Exp Pathol 10(5):5393–5405

    Google Scholar 

  11. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168

    CAS  PubMed  Google Scholar 

  12. Goto Y, De Silva MG, Toscani A, Prabhakar BS, Notkins AL, Lan MS (1992) A novel human insulinoma-associated cDNA, IA-1, encodes a protein with “zinc-finger” DNA-binding motifs. J Biol Chem 267:15252–15257

    CAS  PubMed  Google Scholar 

  13. Breslin MB, Zhu M, Lan MS (2003) NeuroD1/E47 regulates the E-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system. J Biol Chem 278:38991–38997

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lan MS, Breslin MB (2009) Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 23:2024–2033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Carstens PH, Cressman FK Jr (1989) Malignant oncocytic carcinoid of the pancreas. Ultrastruct Pathol 13:69–75

    Article  CAS  PubMed  Google Scholar 

  16. Ohara Y, Oda T, Hashimoto S, Akashi Y, Miyamoto R, Enomoto T, Satomi K, Morishita Y, Ohkohchi N (2016) Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: key immunohistochemical profiles for differential diagnosis. World J Gastroenterol 22:8596–8604

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tang LH, Basturk O, Sue JJ, Klimstra DS (2016) A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol 40:1192–1202

    Article  PubMed  PubMed Central  Google Scholar 

  18. Murata M, Takahashi H, Yamada M, Song M, Hiratsuka M (2017) A case of mixed adenoneuroendocrine carcinoma of the pancreas: immunohistochemical analysis for histogenesis. Medicine (Baltimore) 96:e6225

    Article  Google Scholar 

  19. Hirabayashi K, Kurokawa S, Maruno A, Yamada M, Kawaguchi Y, Nakagohri T, Mine T, Sugiyama T, Tajiri T, Nakamura N (2015) Sex differences in immunohistochemical expression and capillary density in pancreatic solid pseudopapillary neoplasm. Ann Diagn Pathol 19:45–49

    Article  PubMed  Google Scholar 

  20. Burford H, Baloch Z, Liu X, Jhala D, Siegal GP, Jhala N (2009) E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas. Am J Clin Pathol 132:831–839

    Article  CAS  PubMed  Google Scholar 

  21. Yachida S, Zhong Y, Patrascu R, Davis MB, Morsberger LA, Griffin CA, Hruban RH, Laheru D, Iacobuzio-Donahue CA (2011) Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas. Pancreas 40:905–910

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Girardi DM, Silva ACB, Rego JFM, Coudry RA, Riechelmann RP (2017) Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: a systematic review. Cancer Treat Rev 56:28–35

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiki Naito.

Ethics declarations

Conflict of interest

All authors have declared no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanigawa, M., Nakayama, M., Taira, T. et al. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Med Mol Morphol 51, 32–40 (2018). https://doi.org/10.1007/s00795-017-0167-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-017-0167-6

Keywords

Navigation